Zhu Z - Search Results

1

Cell-based selection of internalizing fully human antagonistic antibodies directed against FLT3 for suppression of leukemia cell growth.

Williams B, Atkins A, Zhang H, Lu D, Jimenez X, Li H, Wang MN, Ludwig D, Balderes P, Witte L, Li Y, Zhu Z. Williams B, et al. Among authors: zhu z. Leukemia. 2005 Aug;19(8):1432-8. doi: 10.1038/sj.leu.2403825. Leukemia. 2005. PMID: 15931264

2

Clinical pharmacokinetics and therapeutic efficacy of ceftriaxone in Chinese adults.

Zhu Z, Wang AX, Li Y. Zhu Z, et al. Chemotherapy. 1997 May-Jun;43(3):218-26. doi: 10.1159/000239567. Chemotherapy. 1997. PMID: 9142464

3

Inhibition of vascular endothelial growth factor-induced receptor activation with anti-kinase insert domain-containing receptor single-chain antibodies from a phage display library.

Zhu Z, Rockwell P, Lu D, Kotanides H, Pytowski B, Hicklin DJ, Bohlen P, Witte L. Zhu Z, et al. Cancer Res. 1998 Aug 1;58(15):3209-14. Cancer Res. 1998. PMID: 9699643

4

Monoclonal antibodies targeting the VEGF receptor-2 (Flk1/KDR) as an anti-angiogenic therapeutic strategy.

Witte L, Hicklin DJ, Zhu Z, Pytowski B, Kotanides H, Rockwell P, Böhlen P. Witte L, et al. Among authors: zhu z. Cancer Metastasis Rev. 1998 Jun;17(2):155-61. doi: 10.1023/a:1006094117427. Cancer Metastasis Rev. 1998. PMID: 9770111 Review.

5

Inhibition of vascular endothelial growth factor induced mitogenesis of human endothelial cells by a chimeric anti-kinase insert domain-containing receptor antibody.

Zhu Z, Lu D, Kotanides H, Santiago A, Jimenez X, Simcox T, Hicklin DJ, Bohlen P, Witte L. Zhu Z, et al. Cancer Lett. 1999 Mar 1;136(2):203-13. doi: 10.1016/s0304-3835(98)00324-3. Cancer Lett. 1999. PMID: 10355750

6

Acquired antagonistic activity of a bispecific diabody directed against two different epitopes on vascular endothelial growth factor receptor 2.

Lu D, Kotanides H, Jimenez X, Zhou Q, Persaud K, Bohlen P, Witte L, Zhu Z. Lu D, et al. Among authors: zhu z. J Immunol Methods. 1999 Nov 19;230(1-2):159-71. doi: 10.1016/s0022-1759(99)00135-0. J Immunol Methods. 1999. PMID: 10594363

7

Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors.

Peichev M, Naiyer AJ, Pereira D, Zhu Z, Lane WJ, Williams M, Oz MC, Hicklin DJ, Witte L, Moore MA, Rafii S. Peichev M, et al. Among authors: zhu z. Blood. 2000 Feb 1;95(3):952-8. Blood. 2000. PMID: 10648408 Free article.

8

Inhibition of tumor growth and metastasis by targeting tumor-associated angiogenesis with antagonists to the receptors of vascular endothelial growth factor.

Zhu Z, Witte L. Zhu Z, et al. Invest New Drugs. 1999;17(3):195-212. doi: 10.1023/a:1006314501634. Invest New Drugs. 1999. PMID: 10665474 Review.

9

Identification of the residues in the extracellular region of KDR important for interaction with vascular endothelial growth factor and neutralizing anti-KDR antibodies.

Lu D, Kussie P, Pytowski B, Persaud K, Bohlen P, Witte L, Zhu Z. Lu D, et al. Among authors: zhu z. J Biol Chem. 2000 May 12;275(19):14321-30. doi: 10.1074/jbc.275.19.14321. J Biol Chem. 2000. PMID: 10799512 Free article.

10

An efficient route to the production of an IgG-like bispecific antibody.

Zuo Z, Jimenez X, Witte L, Zhu Z. Zuo Z, et al. Among authors: zhu z. Protein Eng. 2000 May;13(5):361-7. doi: 10.1093/protein/13.5.361. Protein Eng. 2000. PMID: 10835110

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

23,672 results

Search Page

Filters